Therapeutic Advances in Musculoskeletal Disease
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.3 | Q2 | 67.2% | 1.190 | Q1 | 87.9% |
| 2024 | 4.1 | Q1 | 79.3% | 1.348 | Q1 | 90.5% |
| 2023 | 3.4 | Q2 | 71.9% | 1.061 | Q1 | 87.0% |
| 2022 | 4.2 | Q2 | 74.5% | 1.102 | Q1 | 88.3% |
| 2021 | 3.6 | Q3 | 61.5% | 0.818 | Q2 | 81.8% |
| 2020 | — | — | 1.387 | Q1 | 91.2% | |
| 2019 | — | — | 1.475 | Q1 | 92.4% | |
| 2018 | — | — | 1.566 | Q1 | 92.4% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1759-7218
ISSN
1759-720X
country
GBcoverage
2009-2026